Clin2
NCT07041385Possibly a fitNot yet recruiting

Low or standard aspirin dose for preeclampsia prevention in high-risk pregnancy

Preeclampsia (PE)

Treatments studied

Part of Women’s health & pregnancy clinical trials.

This trial compares two doses of aspirin (75 mg vs 150 mg) in pregnant women at high risk for preeclampsia to see which dose works better to prevent the condition.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
340 people
Ages
18 years to 30 years
Study type
Interventional

Who can take part

  • You are between 18 and 30 years old
  • You are between 11 weeks and 13 weeks plus 6 days pregnant
  • You are carrying a single baby (not twins or more)
  • Your estimated risk for early preeclampsia is greater than 1 in 100
  • You screened positive for high risk of preeclampsia

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06802861Recruiting
Aspirin metabolism in pregnant women at risk of pre-eclampsia

This study looks at how pregnant women at risk of pre-eclampsia process aspirin and how it affects their metabolism. Researchers will use blood and urine tests, along with body measurements and surveys, to learn more about how aspirin can help prevent pre-eclampsia.

Knoxville, Tennessee
NCT07779057Recruiting· Phase 4
Aspirin dose to prevent preeclampsia

This trial compares two different doses of aspirin (a common safe medication) to see if one works better at preventing preeclampsia, a pregnancy complication, in women at higher risk. Taking part may help doctors find the best way to protect both you and your baby.

Multan, Punjab Province
NCT07373756Not yet recruiting· Phase 4
Aspirin 75mg vs 150mg to prevent preeclampsia in high-risk pregnancy

This trial compares two doses of aspirin (75mg vs 150mg) to find which is better at preventing preeclampsia in pregnant women at high risk. If you are at increased risk for preeclampsia, this could help protect you and your baby.

NCT06952712Not yet recruiting· Phase 3
Aspirin 150 mg vs 100 mg to Prevent Preeclampsia in High-Risk Obese Pregnant Women

This trial tests whether a higher dose of aspirin (150 mg) works better than the standard dose (100 mg) to prevent preeclampsia, a serious pregnancy complication, in women with obesity who are at increased risk. If you are between 12 and 16 weeks pregnant with one baby and have a high BMI, you may be able to join.

Guangzhou, Guangdong
NCT07665853Not yet recruiting· Phase 3
Aspirin to prevent preeclampsia in high-risk pregnancies

This trial tests whether a shorter course of aspirin can safely prevent preeclampsia in pregnant people who are already at high risk and taking daily aspirin. It aims to find the best time to stop the medication while still protecting both mother and baby.

Vienna
NCT06468202Recruiting· Phase 4
Aspirin dose study to prevent high blood pressure in pregnancy

This trial compares two doses of aspirin to see which is better at preventing conditions like preeclampsia (a serious form of high blood pressure during pregnancy). You may qualify if you are in early pregnancy and have certain risk factors.

Birmingham, Alabama

Hear when a new Preeclampsia (PE) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.